Current USPSTF Screening Guidelines for the 11 Cancer Types Queried
| Cancer Type | Screening Guideline |
|---|---|
| Bladder | The USPSTF concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults. |
| Breast | The USPSTF recommends biennial screening mammography for women aged 50 to 74 years. |
| Cervical | The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting). |
| Colorectal | The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years. |
| Lung | The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. |
| Ovarian | The USPSTF recommends against screening for ovarian cancer in asymptomatic women. |
| Pancreatic | The USPSTF recommends against screening for pancreatic cancer in asymptomatic adults. |
| Prostate | For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)-based screening for prostate cancer should be an individual one. Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision. |
| Skin | The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adults. |
| Testicular | The USPSTF recommends against screening for testicular cancer in adolescent or adult men. |
| Thyroid | The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. |
USPSTF = US Preventive Services Task Force.